Cannabinoids in clinical practice. Williamson, Elizabeth, et al.
Drugs. 2000 Dec, 60(6): 1303-1314 (abstract).
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Malfait, A M, et al.
Proceedings of the National Academy of Sciences. 2000, 97(17): 9561-9566.
Prevention and therapy of cancer by dietary monoterpenes. Crowell, Pamela L
Journal of Nutrition. 1999, 129(3): 775s-778s.
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Ben-Shabat, Shimon, et al.
European Journal of Pharmacology. 1998 353: 23-31 (abstract).
Essential oil of cannabis sativa L. strains. Mediavilla, Vito, et al.
Journal of the International Hemp Association. 1997, 4(2): 82-85.
Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice. Yu, Suzanne G, et al.
Journal of Nutrition. 1995, 125(11): 2763-2767 (abstract).
Chemical ecology of cannabis. Pate, David W
Journal of the International Hemp Association. 1994, 2: 29, 32-37.
Action of cannabidiol on the anxiety and others effects produced by ∆9-thc in normal subjects. Zuardi, A W, et al.
Psychopharmacology. 1982 76: 245-250 (abstract).
Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice. Karler, Ralph
British Journal of Pharmacology. 1980 Mar, 68(3): 479-484.
On the preparation of the Indian hemp or gunjah. O’Shaughnessy, W B, et al.
Provincial Medical Journal. 1843, no. 123: 363-369.